Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sunitinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Sunitinib malate (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Bevacizumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Ranibizumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Pegaptanib sodium (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Sorafenib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Pegaptanib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Vandetanib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Axitinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Sorafenib tosylate (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Cabozantinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Lenvatinib mesilate |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Pazopanib hydrochloride (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Pazopanib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Lenvatinib |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Ramucirumab |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Regorafenib |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Aflibercept |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Brolucizumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Cabozantinib s-malate |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Faricimab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Fruquintinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|